Nico Corp. said today that it raised nearly $13 million in a Series B round from a group of existing backers for its line of neurosurgery devices.

Indianapolis-based Nico said the $12.5 million round is earmarked for new product development and commercialization, clinical and economic studies, growing its sales and clinical teams, and expanding its footprint in Europe.

Read full article from Mass Device here. 

The Learning Lab at IMSH featured Ran Bronstein, VP, CTO who spoke about Patient Specific Simulation for laparoscopy, robotic surgery and arthroscopy as part of the future of patient oriented healthcare. https://t.co/XBLDlA6nLh #IMSH2020 #simulation #medicaleducation #laparoscopy